- CH₣31.10bn
- CH₣34.30bn
- $11.16bn
Swiss stocks - Factors to watch on September 25
Brief: Sandoz Launches Affordable Iron Sucrose Injection
Roche CEO, pharma execs to meet with Swiss government over US tariffs
Bristol Myers to sell 60% stake in China joint venture
Europe Research Roundup: Acciona, Danone, EasyJet
Swiss stocks - Factors to watch on September 16
Swiss stocks - Factors to watch on September 9
Brief: Sandoz Group Reaches Agreement With Regeneron, Resolving Patent Litigation Related To Its U.S. Aflibercept Biosimilar
Brief: Sandoz Launches Rivaroxaban In Germany, Expanding Access To High-Quality Antithrombotic Treatment Options
Europe Research Roundup: Bioinvent, Diasorin, Sandoz
Europe Research Roundup: Accor, Equinor, Siemens
Brief: Sandoz Launches Renewable Energy Partnership
Top of the Street: Bankinter, Diageo, Sandoz Group
Sandoz at record high after H1 beat
Brief: Sandoz H1 Sales USD 5,232 Million
Swiss stocks - Factors to watch on August 7
Sandoz to offer generic weight-loss drugs in Canada at up to 70% discount, FT reports (updated)
Swiss stocks - Factors to watch on August 5
Brief: Sandoz Targets 70% Price Cut For Weight-Loss Drugs In Canada - FT